⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRX News
Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal to Report Second Quarter 2026 Results on July 30, 2026
globenewswire.com
AMRX
Post-Bariatric Hypoglycemia Market to Register Stunning Growth at a 16.4% CAGR Through 2036 Owing to the Emergence of Novel Drug Classes Such as GLP-1 Receptor Antagonists, SGLT1 Inhibitors, CRH Inhibitors, and SSTR5 Agonists | DelveInsight
prnewswire.com
AMRX
NVO
AMGN
REGN
GSK
SNY
AZN
PFE
BMRA
MRK
Oncology Precision Medicine Market Trends & Opportunities Forecast 2021-2031
globenewswire.com
AMRX
NTRA
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
globenewswire.com
AMRX
Zambon annonce un avis favorable du CHMP concernant le médicament Hopledo® (IPX203) destiné aux patients adultes atteints de la maladie de Parkinson et présentant des fluctuations motrices modérées à sévères
businesswire.com
AMRX
Zambon annuncia il parere positivo del CHMP per Hopledo® (IPX203) nei pazienti adulti con Malattia di Parkinson e fluttuazioni motorie da moderate a severe
businesswire.com
AMRX
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
businesswire.com
AMRX
Ritedose Commits to National "Hope Alliance" Campaign to Support Uninsured Patients
prnewswire.com
VTRS
AMRX
ARX
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
globenewswire.com
RPTX
AMRX
Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals
prnewswire.com
AMRX